Preferred Label : cifenline;
CISMeF synonym : Bristol-Myers squibb brand of cifenline succinate; cifenline succinate; cipralan; exacor; pharmacia brand of cifenline succinate;
MeSH synonym : 2-(2,2-diphenylcyclopropyl)-2-imidazoline; cibenzoline;
MeSH hyponym : cibenzoline succinate;
MeSH Related Number : cifenline, (S)-isomer; 103419-18-7 ((S)-isomer); 53267-01-9 (cifenline); 38G16RWJ37;
Registry Number MeSH : 53267-01-9;
Related CAS MeSH : 103419-18-7 (cifenline, (S)-isomer);
related registry number list (CISMeF) : 103419-18-7 ((S)-isomer);
Codes EINECS : 258-453-7;
Is substance : O;
UNII : Z7489237QT;
InChIKey : IPOBOOXFSRWSHL-UHFFFAOYSA-N;
Origin ID : C032151;
UMLS CUI : C0055720;
ATC code(s)
CISMeF manual mappings
MeSH term(s) associated for indexing
Pharmacological action(s)
Record concept(s)
Semantic type(s)
UMLS correspondences (same concept)
https://www.has-sante.fr/jcms/p_3210118/fr/exacor
2020
false
false
false
France
treatment outcome
insurance, health, reimbursement
cifenline succinate
administration, oral
recurrence
tachycardia, supraventricular
tachycardia, ventricular
Ventricular Arrhythmia
anti-arrhythmia agents
cibenzoline
guidelines for drug use
evaluation of the transparency committee
cifenline
imidazoles
---
http://www.has-sante.fr/portail/jcms/c_1352563/cipralan
http://www.has-sante.fr/portail/upload/docs/evamed/CT-12410_CIPRALAN_RI_avis2_CT12410.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_631274
2012
France
French
secondary prevention
tablets
cifenline
anti-arrhythmia agents
administration, oral
insurance, health, reimbursement
cibenzoline
tachycardia, ventricular
tachycardia, supraventricular
evaluation of the transparency committee
cifenline succinate
imidazoles
---
http://www.has-sante.fr/portail/display.jsp?id=c_631231
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct-3591_exacor_.pdf
2008
France
French
secondary prevention
cifenline
imidazoles
anti-arrhythmia agents
administration, oral
cibenzoline
insurance, health, reimbursement
tachycardia, supraventricular
tachycardia, ventricular
tablets
imidazoles
evaluation of the transparency committee
---